STERIS Continues To Expect As Reported Revenue From Continuing Operations To Increase 6.5-7.5% In Fiscal 2025; Adjusted EPS To Be In The Range Of $9.05-$9.25 Vs $9.14 Est.
Portfolio Pulse from Benzinga Newsdesk
STERIS expects its reported revenue from continuing operations to increase by 6.5-7.5% in fiscal 2025. The company completed a divestiture of its Controlled Environment Services business, which will be excluded from revenue growth calculations. Adjusted earnings per diluted share are anticipated to be between $9.05 and $9.25, up from $8.20 in fiscal 2024. Capital expenditures are expected to be around $360 million, with free cash flow projected at $700 million.
August 06, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
STERIS expects a 6.5-7.5% increase in reported revenue from continuing operations in fiscal 2025. Adjusted earnings per diluted share are anticipated to be between $9.05 and $9.25, up from $8.20 in fiscal 2024. The company completed a divestiture of its Controlled Environment Services business, which will be excluded from revenue growth calculations.
The positive revenue and earnings outlook for fiscal 2025, along with the divestiture of a non-core business, suggests a strong financial performance. This is likely to have a positive short-term impact on STE's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100